LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis

Traffic

Volumn 15, Issue 12, 2014, Pages 1390-1405

  Holland, Petter ^a   Torgersen, Maria L ^a,b   Sandvig, Kirsten ^b   Simonsen, Anne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

AP 3; Autophagy; Beige; Cathepsin B; CHS; CI MPR; CtxB; EGFR; Endocytosis; LC3; LLPD; Lysosome; LYST; Ricin; Transferrin

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; OLIGONUCLEOTIDE; PROTEIN; PROTEIN LYST; SMALL INTERFERING RNA; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG; LYST PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL LYSATE; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HELA CELL LINE; HUMAN; HUMAN CELL; LYSOSOME; LYSOSOME MEMBRANE; PH; PHENOTYPE; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TRANS GOLGI NETWORK; TRANSPORT VESICLE; U2OS CELL LINE; WESTERN BLOTTING; CELL CULTURE; CHEDIAK HIGASHI SYNDROME; GENETICS; METABOLISM; PROTEIN TRANSPORT; TUMOR CELL LINE;

ADAPTOR PROTEIN COMPLEX 3; AUTOPHAGY; CELL LINE, TUMOR; CELLS, CULTURED; CHEDIAK-HIGASHI SYNDROME; ENDOCYTOSIS; HUMANS; LYSOSOMES; PROTEIN TRANSPORT; PROTEOLYSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 2; VESICULAR TRANSPORT PROTEINS;

EID: 84911985674     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12227     Document Type: Article

References (48)

1. Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault BJ, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996;14:307-311.
2. Barbosa MDFS, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, Brandt SJ, Chotai D, Hodgman C, Solari RCE, Lovett M, Kingsmore SF. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996;382:262-265.
3. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999;68:283-303.
4. Kaplan McVey Ward DD, Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol 2008;15:22-29.
5. Blume RS, Wolff SM. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine 1972;51:247-280.
6. Rubin CM, Burke BA, McKenna RW, McClain KL, White JG, Nesbit ME Jr, Filipovich AH. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer 1985;56:524-530.
7. Certain S, Barrat F, Pastural E, Deist FL, Goyo-Rivas J, Jabado N, Benkerrou M, Seger R, Vilmer E, Beullier G, Schwarz K, Fischer A, Basile GdS. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood 2000;95:979-983.
8. Merino F, Klein GO, Henle W, Ramirez-Duque P, Forsgren M, Amesty C. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome. Clin Immunol Immunopathol 1983;27:326-339.
9. Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E, Griscelli C, Fischer a. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995;85:3328-3333.
10. Kazmierowski JAER, Reynolds HY, Durbin WA, Wolff SM. Chediak-Higashi syndrome: reversal of increased susceptibility to infection by bone marrow transplantation. Blood 1976;47:555-559.
11. Chediak M. Nouvelle anomalie leukocytaire de caractere constitutionnel et familiel. Rev Hematol 1952;7:362-367.
12. Higashi O. Congenital gigantism of peroxidase granules; the first case ever reported of qualitative abnormity of peroxidase. Tohoku J Exp Med 1954;59:315-332.
13. Burkhardt JK, Fa Wiebel, Hester S, Argon Y. The giant organelles in beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes. J Exp Med 1993;178:1845-1856.
14. Roder JC, Haliotis T, Klein M, Korec S, Jett JR, Ortaldo J, Heberman RB, Katz P, Fauci AS. A new immunodeficiency disorder in humans involving NK cells. Nature 1980;284:553-555.
15. Baetz K, Isaaz S, Griffiths GM. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. J Immunol 1995;154:6122-6131.
16. Zelickson aS, Windhorst DB, White JG, Good Ra. The Chediak-Higashi syndrome: formation of giant melanosomes and the basis of hypopigmentation. J Invest Dermatol 1967;49:575-581.
17. Windhorst DB, Zelickson S, Good R. A human pigmentary dilution based on a heritable subcellular structural defect--the Chediak-Higashi syndrome. J Invest Dermatol 1968;50:9-18.
18. Haliotis T, Roder J, Klein M, Ortaldo J, Fauci AS, Herberman RB. Chédiak-Higashi gene in humans I. Impairment of natural-killer function. J Exp Med 1980;151:1039-1048.
19. Stinchcombe JC, Page LJ, Griffiths GM. Secretory lysosome biogenesis in cytotoxic T lymphocytes from normal and Chediak Higashi syndrome patients. Traffic 2000;1:435-444.
20. Faigle W, Raposo G, Tenza D, Pinet V, Vogt AB, Kropshofer H, Fischer A, de Saint-Basile G, Amigorena S. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol 1998;141:1121-1134.
21. Wilson J, Huynh C, Ka Kennedy, Ward DM, Kaplan J, Aderem A, Andrews NW. Control of parasitophorous vacuole expansion by LYST/beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog 2008;4:e1000179.
22. Perou CM, Leslie JD, Green W, Li L, Ward DM, Kaplan J. The beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J Biol Chem 1997;272:29790-29794.
23. Durchfort N, Verhoef S, Vaughn MB, Shrestha R, Adam D, Kaplan J, Ward DM. The enlarged lysosomes in beige cells result from decreased lysosome fission and not increased lysosome fusion. Traffic 2012;13:108-119.
24. Ward DM, Shiflett SL, Huynh D, Vaughn MB, Prestwich G, Kaplan J. Use of expression constructs to dissect the functional domains of the CHS/beige protein: identification of multiple phenotypes. Traffic 2003;4:403-415.
25. Hammel I, Lagunoff D, Galli SJ. Regulation of secretory granule size by the precise generation and fusion of unit granules. J Cell Mol Med 2010;14:1904-1916.
26. Rahman M, Haberman A, Tracy C, Ray S, Krämer H. Drosophila mauve mutants reveal a role of LYST homologs late in the maturation of phagosomes andautophagosomes. Traffic 2012;13:1680-1692.
27. Kanfer JN, Blume RS, Yankee RA, Wolff SM. Alteration of sphingolipid metabolism in leukocytes from patients with the Chediak-Higashi syndrome. N Engl J Med 1968;279:410-413.
28. Ito M, Tanabe F, Takami Y, Sato A, Shigeta S. Rapid down-regulation of protein kinase C and beige mouse by phorbol ester. Biochem Biophys Res Commun 1988;153:648-656.
29. Ito M, Sato A, Tanabe F, Ishida E, Takami Y, Shigeta S. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in beige mouse. Biochem Biophys Res Commun 1989;160:433-434.
30. Tanabe F, Cui SH, Ito M. Abnormal down-regulation of PKC is responsible for giant granule formation in fibroblasts from CHS (beige) mice--a thiol proteinase inhibitor, E-64-d, prevents giant granule formation in beige fibroblasts. J Leukoc Biol 2000;67:749-755.
31. Cui SH, Tanabe F, Terunuma H, Iwatani Y, Nunoi H, Agematsu K, Komiyama a, Nomura a, Hara T, Onodera T, Iwata T, Ito M. A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity. Clin Exp Immunol 2001;125:283-290.
32. Mohlig H, Mathieu S, Thon L, Frederiksen MC, Ward DM, Kaplan J, Schutze S, Kabelitz D, Adam D. The WD repeat protein FAN regulates lysosome size independent from abnormal downregulation/membrane recruitment of protein kinase C. Exp Cell Res 2007;313:2703-2718.
33. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010;141:290-303.
34. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011;334:678-683.
35. Zhang H, Mahuran DJ, Callahan JW. Identification of proteins in the ceroid-like autofluorescent aggregates from liver lysosomes of beige, a mouse model for human Chediak-Higashi syndrome. Mol Genet Metab 2010;99:389-395.
36. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012;8:445-544.
37. Martin KR, Barua D, Kauffman AL, Westrate LM, Posner RG, Hlavacek WS, Mackeigan JP. Computational model for autophagic vesicle dynamics in single cells. Autophagy 2013;9:74-92.
38. Chan EY, Kir S, Tooze SA. siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J Biol Chem 2007;282:25464-25474.
39. Lu Q, Hope LW, Brasch M, Reinhard C, Cohen SN. TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci U S A 2003;100:7626-7631.
40. Lencer WI, Hirst TR, Holmes RK. Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta 1999;1450:177-190.
41. Sandvig K, van Deurs B. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol Rev 1996;76:949-966.
42. Peden AA, Oorschot V, Hesser BA, Austin CD, Scheller RH, Klumperman J. Localization of the AP-3 adaptor complex defines a novel endosomal exit site for lysosomal membrane proteins. J Cell Biol 2004;164:1065-1076.
43. Korolchuk VI, Saiki S, Lichtenberg M, Siddiqi FH, Roberts EA, Imarisio S, Jahreiss L, Sarkar S, Futter M, Menzies FM, O'Kane CJ, Deretic V, Rubinsztein DC. Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol 2011;13:453-460.
44. Rusten TE, Lindmo K, Juhasz G, Sass M, Seglen PO, Brech A, Stenmark H. Programmed autophagy in the Drosophila fat body is induced by ecdysone through regulation of the PI3K pathway. Dev Cell 2004;7:179-192.
45. Isakson P, Holland P, Simonsen A. The role of ALFY in selective autophagy. Cell Death Differ 2013;20:12-20.
46. Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 1999;3:11-21.
47. Ward DM, Griffiths GM, Stinchcombe JC, Kaplan J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 2000;1:816-822.
48. Bohnsack RN, Song X, Olson LJ, Kudo M, Gotschall RR, Canfield WM, Cummings RD, Smith DF, Dahms NM. Cation-independent mannose 6-phosphate receptor: a composite of distinct phosphomannosyl binding sites. J Biol Chem 2009;284:35215-35226.